Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pentostatin
Drug ID BADD_D01730
Description A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
Indications and Usage For the treatment of hairy cell leukaemia refractory to alpha interferon.
Marketing Status approved; investigational
ATC Code L01XX08
DrugBank ID DB00552
KEGG ID D00155
MeSH ID D015649
PubChem ID 439693
TTD Drug ID D0T3AD
NDC Product Code 42533-109; 67457-288; 0409-0801; 14096-124; 59981-005
UNII 395575MZO7
Synonyms Pentostatin | Deoxycoformycin | Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)- | 2'-Deoxycoformycin | 2' Deoxycoformycin | NSC-218321 | NSC 218321 | NSC218321 | Co-Vidarabine | CI-825 | CI 825 | CI825 | Nipent
Chemical Information
Molecular Formula C11H16N4O4
CAS Registry Number 53910-25-1
SMILES C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams17.15.02.001; 19.02.03.001---
Abscess11.01.08.001---
Acne23.02.01.001---
Acute leukaemia01.10.02.001; 16.01.02.001---
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001---
Alopecia23.02.02.001--
Amblyopia06.02.01.001---
Amenorrhoea05.05.01.002; 21.01.02.001--
Amnesia17.03.02.001; 19.20.01.001--
Anaemia01.03.02.0010.000112%
Angina pectoris02.02.02.002; 24.04.04.002--
Anxiety19.06.02.002--
Aplastic anaemia01.03.03.002---
Arrhythmia02.03.02.001---
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Asthenia08.01.01.001---
Asthma10.01.03.010; 22.03.01.002---
Ataxia08.01.02.004; 17.02.02.001--
Atrioventricular block02.03.01.002---
Basal cell carcinoma16.03.02.001; 23.08.02.0010.000112%-
Blood creatinine increased13.13.01.004--
Body temperature increased13.15.01.001---
Bradycardia02.03.02.002---
Breast mass21.05.04.002---
Bronchitis11.01.09.001; 22.07.01.001--
Bronchospasm10.01.03.012; 22.03.01.004--
Cardiac arrest02.03.04.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages